Based on 3 analysts giving stock ratings to Lisata Therapeutics Inc in the past month.
Hold
0 Strong Buy
1 Buy
2 Hold
0 Sell
0 Strong Sell
Target Price
15.000USD+1370.59%
LSTA Analyst Recommendation Trends
In the current month, LSTA has received 1 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. LSTA average Analyst price target in the last month is 15.000.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
Strong Buy
0
0
0
0
0
0
0
0
Buy
1
1
1
2
2
3
3
3
Hold
2
2
2
1
1
0
0
0
Strong Sell
0
0
0
0
0
0
0
0
Sell
0
0
0
0
0
0
0
0
Total
3
3
3
3
3
3
3
3
LSTA Analyst Rating for Peer Comparison
Updated: Nov 5, 2026
Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Ratings
Analysts
argenx SE
ARGX
10
14
3
0
0
27
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Ascendis Pharma A/S
ASND
9
13
1
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
12
6
0
0
22
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
Forecast
--
--
--
Actual
-0.34
-0.50
-0.32
Surprise
--
--
--
FAQs
What is Lisata Therapeutics Inc's price target?
Analysts forecast that Lisata Therapeutics Inc's price target is USD 15.00, with the highest forecast at USD 15.00 and the lowest forecast at USD 15.00.
What is the analyst rating for Lisata Therapeutics Inc?
Based on the ratings of Lisata Therapeutics Inc's stock from 3 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.